Cargando…
CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome
Histone deacetylases have been a target of therapy for organ fibrosis. Here, we report the protective effect of CG200745 (CG), a novel histone deacetylase inhibitor, on tubulointerstitial fibrosis in Col4a3(−/−) mice, a murine model of Alport syndrome. Morphological analyses revealed CG treatment ma...
Autores principales: | Suh, Sang Heon, Choi, Hong Sang, Kim, Chang Seong, Kim, In Jin, Cha, Hyunju, Cho, Joong Myung, Ma, Seong Kwon, Kim, Soo Wan, Bae, Eun Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073208/ https://www.ncbi.nlm.nih.gov/pubmed/32098220 http://dx.doi.org/10.3390/ijms21041473 |
Ejemplares similares
-
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
por: Choi, Hong Sang, et al.
Publicado: (2018) -
Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats
por: Bae, Eun Hui, et al.
Publicado: (2019) -
A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
por: Lee, Hee Seung, et al.
Publicado: (2017) -
Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016) -
Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ
por: Suh, Sang Heon, et al.
Publicado: (2019)